A citation-based method for searching scientific literature

A Fagotti, G Vizzielli, F Fanfani, B Costantini, G Ferrandina, V Gallotta, S Gueli Alletti, L Tortorella, G Scambia. Gynecol Oncol 2013
Times Cited: 72







List of co-cited articles
352 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.
Ignace Vergote, Claes G Tropé, Frédéric Amant, Gunnar B Kristensen, Tom Ehlen, Nick Johnson, René H M Verheijen, Maria E L van der Burg, Angel J Lacave, Pierluigi Benedetti Panici,[...]. N Engl J Med 2010
62

Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial.
Sean Kehoe, Jane Hook, Matthew Nankivell, Gordon C Jayson, Henry Kitchener, Tito Lopes, David Luesley, Timothy Perren, Selina Bannoo, Monica Mascarenhas,[...]. Lancet 2015
635
41

Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma.
Anna Fagotti, Gabriella Ferrandina, Francesco Fanfani, Giorgia Garganese, Giuseppe Vizzielli, Vito Carone, Maria Giovanna Salerno, Giovanni Scambia. Am J Obstet Gynecol 2008
161
38

A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.
Rudy S Suidan, Pedro T Ramirez, Debra M Sarasohn, Jerrold B Teitcher, Svetlana Mironov, Revathy B Iyer, Qin Zhou, Alexia Iasonos, Harold Paul, Masayoshi Hosaka,[...]. Gynecol Oncol 2014
124
31

Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.
Robert E Bristow, Rafael S Tomacruz, Deborah K Armstrong, Edward L Trimble, F J Montz. J Clin Oncol 2002
29

A multicentric trial (Olympia-MITO 13) on the accuracy of laparoscopy to assess peritoneal spread in ovarian cancer.
Anna Fagotti, Giuseppe Vizzielli, Pierandrea De Iaco, Daniela Surico, Alessandro Buda, Vincenzo Dario Mandato, Francesco Petruzzelli, Fabio Ghezzi, Salvatore Garzarelli, Liliana Mereu,[...]. Am J Obstet Gynecol 2013
75
27


Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.
Dennis S Chi, Eric L Eisenhauer, Oliver Zivanovic, Yukio Sonoda, Nadeem R Abu-Rustum, Douglas A Levine, Matthew W Guile, Robert E Bristow, Carol Aghajanian, Richard R Barakat. Gynecol Oncol 2009
376
26

An analysis of patients with bulky advanced stage ovarian, tubal, and peritoneal carcinoma treated with primary debulking surgery (PDS) during an identical time period as the randomized EORTC-NCIC trial of PDS vs neoadjuvant chemotherapy (NACT).
Dennis S Chi, Fernanda Musa, Fanny Dao, Oliver Zivanovic, Yukio Sonoda, Mario M Leitao, Douglas A Levine, Ginger J Gardner, Nadeem R Abu-Rustum, Richard R Barakat. Gynecol Oncol 2012
183
25

A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: a pilot study.
Anna Fagotti, Gabriella Ferrandina, Francesco Fanfani, Alfredo Ercoli, Domenica Lorusso, Marco Rossi, Giovanni Scambia. Ann Surg Oncol 2006
184
25

Influence of intraperitoneal dissemination assessed by laparoscopy on prognosis of advanced ovarian cancer: an exploratory analysis of a single-institution experience.
Giuseppe Vizzielli, Barbara Costantini, Lucia Tortorella, Marco Petrillo, Francesco Fanfani, Vito Chiantera, Alfredo Ercoli, Raffaella Iodice, Giovanni Scambia, Anna Fagotti. Ann Surg Oncol 2014
32
43

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.
Deborah K Armstrong, Brian Bundy, Lari Wenzel, Helen Q Huang, Rebecca Baergen, Shashikant Lele, Larry J Copeland, Joan L Walker, Robert A Burger. N Engl J Med 2006
18

Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: proof of a concept.
M Petrillo, G Vizzielli, F Fanfani, V Gallotta, F Cosentino, V Chiantera, F Legge, V Carbone, G Scambia, A Fagotti. Gynecol Oncol 2015
72
18

Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment.
Giovanni D Aletti, Eric L Eisenhauer, Antonio Santillan, Allison Axtell, Giacomo Aletti, Christine Holschneider, Dennis S Chi, Robert E Bristow, William A Cliby. Gynecol Oncol 2011
151
16

What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?
D S Chi, E L Eisenhauer, J Lang, J Huh, L Haddad, N R Abu-Rustum, Y Sonoda, D A Levine, M Hensley, R R Barakat. Gynecol Oncol 2006
419
16

The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer.
Barry Rosen, Stephane Laframboise, Sarah Ferguson, Jason Dodge, Marcus Bernardini, Joan Murphy, Yakir Segev, Ping Sun, Steven A Narod. Gynecol Oncol 2014
75
16

Relative influences of tumor volume before surgery and the cytoreductive outcome on survival for patients with advanced ovarian cancer: a prospective study.
Scott M Eisenkop, Nick M Spirtos, Richard L Friedman, Wei-Chien Michael Lin, Albert L Pisani, Sergio Perticucci. Gynecol Oncol 2003
267
15

Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer.
Allison E Axtell, Margaret H Lee, Robert E Bristow, Sean C Dowdy, William A Cliby, Steven Raman, John P Weaver, Mojan Gabbay, Michael Ngo, Scott Lentz,[...]. J Clin Oncol 2007
165
15

The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma.
W J Hoskins, W P McGuire, M F Brady, H D Homesley, W T Creasman, M Berman, H Ball, J S Berek. Am J Obstet Gynecol 1994
531
15

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.
William E Winter, G Larry Maxwell, Chunqiao Tian, Jay W Carlson, Robert F Ozols, Peter G Rose, Maurie Markman, Deborah K Armstrong, Franco Muggia, William P McGuire. J Clin Oncol 2007
586
13

Role of laparoscopy to assess the chance of optimal cytoreductive surgery in advanced ovarian cancer: a pilot study.
Anna Fagotti, Francesco Fanfani, Manuela Ludovisi, Roberto Lo Voi, Giuseppe Bifulco, Antonia Carla Testa, Giovanni Scambia. Gynecol Oncol 2005
80
13

Laparoscopy for diagnosing resectability of disease in patients with advanced ovarian cancer.
Marianne J Rutten, Mariska M G Leeflang, Gemma G Kenter, Ben Willem J Mol, Marrije Buist. Cochrane Database Syst Rev 2014
42
23




Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial.
Marianne J Rutten, Hannah S van Meurs, Roelien van de Vrie, Katja N Gaarenstroom, Christiana A Naaktgeboren, Toon van Gorp, Henk G Ter Brugge, Ward Hofhuis, Henk W R Schreuder, Henriette J G Arts,[...]. J Clin Oncol 2017
65
15

Laparoscopy to predict the result of primary cytoreductive surgery in advanced ovarian cancer patients (LapOvCa-trial): a multicentre randomized controlled study.
Marianne J Rutten, Katja N Gaarenstroom, Toon Van Gorp, Hannah S van Meurs, Henriette Jg Arts, Patrick M Bossuyt, Henk G Ter Brugge, Ralph Hm Hermans, Brent C Opmeer, Johanna Ma Pijnenborg,[...]. BMC Cancer 2012
34
26

Optimal primary surgical treatment for advanced epithelial ovarian cancer.
Ahmed Elattar, Andrew Bryant, Brett A Winter-Roach, Mohamed Hatem, Raj Naik. Cochrane Database Syst Rev 2011
216
12

The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
Eric L Eisenhauer, Nadeem R Abu-Rustum, Yukio Sonoda, Douglas A Levine, Elizabeth A Poynor, Carol Aghajanian, William R Jarnagin, Ronald P DeMatteo, Michael I D'Angelica, Richard R Barakat,[...]. Gynecol Oncol 2006
219
12

Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.
Anna Fagotti, Gabriella Ferrandina, Giuseppe Vizzielli, Francesco Fanfani, Valerio Gallotta, Vito Chiantera, Barbara Costantini, Pasquale Alessandro Margariti, Salvatore Gueli Alletti, Francesco Cosentino,[...]. Eur J Cancer 2016
203
12

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.
Dennis S Chi, Corinna C Franklin, Douglas A Levine, Faina Akselrod, Paul Sabbatini, William R Jarnagin, Ronald DeMatteo, Elizabeth A Poynor, Nadeem R Abu-Rustum, Richard R Barakat. Gynecol Oncol 2004
228
11

A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography.
R E Bristow, L R Duska, N C Lambrou, E K Fishman, M J O'Neill, E L Trimble, F J Montz. Cancer 2000
208
11

The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma.
Sean C Dowdy, Sally A Mullany, Kathy R Brandt, Bonnie J Huppert, William A Cliby. Cancer 2004
130
11

A framework for a personalized surgical approach to ovarian cancer.
Alpa M Nick, Robert L Coleman, Pedro T Ramirez, Anil K Sood. Nat Rev Clin Oncol 2015
89
11

Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182.
Neil S Horowitz, Austin Miller, Bunja Rungruang, Scott D Richard, Noah Rodriguez, Michael A Bookman, Chad A Hamilton, Thomas C Krivak, G Larry Maxwell. J Clin Oncol 2015
142
11

Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline.
Alexi A Wright, Kari Bohlke, Deborah K Armstrong, Michael A Bookman, William A Cliby, Robert L Coleman, Don S Dizon, Joseph J Kash, Larissa A Meyer, Kathleen N Moore,[...]. J Clin Oncol 2016
211
11

Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial.
Hannah S van Meurs, Parvin Tajik, Michel H P Hof, Ignace Vergote, Gemma G Kenter, Ben Willem J Mol, Marrije R Buist, Patrick M Bossuyt. Eur J Cancer 2013
73
9

Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery?
A Fagotti, F Fanfani, G Vizzielli, V Gallotta, A Ercoli, A Paglia, B Costantini, M Vigliotta, G Scambia, G Ferrandina. Gynecol Oncol 2010
43
16

Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial.
G Ferrandina, G Sallustio, A Fagotti, G Vizzielli, A Paglia, E Cucci, A Margariti, L Aquilani, G Garganese, G Scambia. Br J Cancer 2009
61
11

Staging laparoscopy for the management of early-stage ovarian cancer: a metaanalysis.
Hyun Jong Park, Dong Wook Kim, Ga Won Yim, Eun Ji Nam, Sunghoon Kim, Young Tae Kim. Am J Obstet Gynecol 2013
43
16

2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference.
Gavin C E Stuart, Henry Kitchener, Monica Bacon, Andreas duBois, Michael Friedlander, Jonathan Ledermann, Christian Marth, Tate Thigpen, Edward Trimble. Int J Gynecol Cancer 2011
287
9

Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience.
Giovanni D Aletti, Sean C Dowdy, Bobbie S Gostout, Monica B Jones, Robert C Stanhope, Timothy O Wilson, Karl C Podratz, William A Cliby. J Am Coll Surg 2009
75
9


Aggressive surgical effort and improved survival in advanced-stage ovarian cancer.
Giovanni D Aletti, Sean C Dowdy, Bobbie S Gostout, Monica B Jones, C Robert Stanhope, Timothy O Wilson, Karl C Podratz, William A Cliby. Obstet Gynecol 2006
311
9

Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer.
D S Alberts, P Y Liu, E V Hannigan, R O'Toole, S D Williams, J A Young, E W Franklin, D L Clarke-Pearson, V K Malviya, B DuBeshter. N Engl J Med 1996
891
9

Maximal cytoreduction in patients with FIGO stage IIIC to stage IV ovarian, fallopian, and peritoneal cancer in day-to-day practice: a Retrospective French Multicentric Study.
Mathieu Luyckx, Eric Leblanc, Thomas Filleron, Philippe Morice, Emile Darai, Jean-Marc Classe, Gwenaël Ferron, Eberhard Stoeckle, Christophe Pomel, Bénédicte Vinet,[...]. Int J Gynecol Cancer 2012
77
9

Incorporation of bevacizumab in the primary treatment of ovarian cancer.
Robert A Burger, Mark F Brady, Michael A Bookman, Gini F Fleming, Bradley J Monk, Helen Huang, Robert S Mannel, Howard D Homesley, Jeffrey Fowler, Benjamin E Greer,[...]. N Engl J Med 2011
9

A phase 3 trial of bevacizumab in ovarian cancer.
Timothy J Perren, Ann Marie Swart, Jacobus Pfisterer, Jonathan A Ledermann, Eric Pujade-Lauraine, Gunnar Kristensen, Mark S Carey, Philip Beale, Andrés Cervantes, Christian Kurzeder,[...]. N Engl J Med 2011
9

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).
E A Eisenhauer, P Therasse, J Bogaerts, L H Schwartz, D Sargent, R Ford, J Dancey, S Arbuck, S Gwyther, M Mooney,[...]. Eur J Cancer 2009
9



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.